Michael T. Andriole
CIK 1698751 · PRESIDENT AND CEO · last filed 2025-04-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
25
Lifetime Open-Market Net
-$36.3K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CHIMERIX INC (CMRX) Delisted | PRESIDENT AND CEO | 0 | $8.54 | $0 | $242.5K | 19 | 2025-04-21 |
| ENDOCYTE INC (ECYT) Delisted | Chief Financial Officer | 0 | — | — | -$278.8K | 6 | 2018-12-21 |
Recent Filings · Page 3 of 3
25 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-12-19 | ENDOCYTE INC (ECYT) Delisted | Mixed | +20,500 | $55.5K | EDGAR |
| 2018-10-09 | ENDOCYTE INC (ECYT) Delisted | Sell (S) | −17,918 | -$278.8K | EDGAR |
| 2018-02-08 | ENDOCYTE INC (ECYT) Delisted | Grant (A) | +25,000 | $0 | EDGAR |
| 2017-10-06 | ENDOCYTE INC (ECYT) Delisted | Grant (A) | +75,000 | $0 | EDGAR |
| 2017-02-22 | ENDOCYTE INC (ECYT) Delisted | Grant (A) | +50,000 | $0 | EDGAR |
Showing 21–25 of 25
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.